Effect of ombitasvir/paritaprevir/ritonavir (ombitasvir/ABT-450/r) and dasabuvir with or without ribavirin (RBV) co-administered with HIV protease inhibitors (atazanavir, darunavir, lopinavir) in healthy subjects.

Trial Profile

Effect of ombitasvir/paritaprevir/ritonavir (ombitasvir/ABT-450/r) and dasabuvir with or without ribavirin (RBV) co-administered with HIV protease inhibitors (atazanavir, darunavir, lopinavir) in healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Feb 2015

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top